Standout Papers

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disea... 1997 2026 2006 2016 1.7k
  1. A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease (1997)
    Mary Sano, Christopher Ernesto et al. New England Journal of Medicine
  2. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. (1997)
    Doug Galasko, David Bennett et al. PubMed

Immediate Impact

2 by Nobel laureates 16 from Science/Nature 109 standout
Sub-graph 1 of 17

Citing Papers

Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease
2023 Standout
Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
2019 Standout
76 intermediate papers

Works of Christopher Ernesto being referenced

An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
1997 Standout
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.
1997
and 2 more

Author Peers

Author Last Decade Papers Cites
Christopher Ernesto 1612 347 699 1515 11 3.6k
Shelia Jin 1230 243 885 1450 27 3.8k
Kimberly Schafer 1488 301 934 1843 38 4.6k
Ara S. Khachaturian 1347 174 813 1704 47 4.1k
Eric Pfeiffer 2645 639 1157 2742 40 9.8k
Kazuo Hasegawa 2428 271 427 1443 26 5.0k
J. M. Orgogozo 969 99 378 1362 40 3.5k
Elizabeth Rimmer 1890 235 316 1204 9 4.0k
H. Michael Arrighi 1863 253 562 2038 51 6.1k
Kate Zhong 1376 346 1338 2542 34 5.2k
Naji Tabet 1139 81 452 1371 97 3.8k

All Works

Loading papers...

Rankless by CCL
2026